Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Open, Comparative Trial Of Maraviroc Versus Etravirine Each In Combination With Darunavir/Ritonavir And Raltegravir For The Treatment Of Antiretroviral-Experienced HIV-1 Subjects Co-Infected With Hepatitis C And/Or Hepatitis B

NCT00782301 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT00782301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00782301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Open, Comparative Trial Of Maraviroc Versus Etravirine Each In Combination With Darunavir/Ritonavir And Raltegravir For The Treatment Of Antiretroviral-Experienced HIV-1 Subjects Co-Infected With Hepatitis C And/Or Hepatitis B
Lead sponsor
ViiV Healthcare
Phase
Phase 4
Overall status
Withdrawn
Start date
March 31, 2009
Completion date
February 28, 2010
Enrollment
0 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, hepatitis c, chronic, human immunodeficiency virus